X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26) 26
index medicus (21) 21
male (21) 21
aged (15) 15
female (15) 15
middle aged (15) 15
hematology (10) 10
oncology (9) 9
adult (8) 8
aged, 80 and over (8) 8
analysis (8) 8
pharmacology & pharmacy (7) 7
prognosis (7) 7
cancer (6) 6
kaplan-meier estimate (6) 6
rituximab (6) 6
chemotherapy (5) 5
lymphomas (5) 5
time factors (5) 5
treatment outcome (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
b-cell lymphoma (4) 4
diffuse large b-cell lymphoma (4) 4
disease-free survival (4) 4
elderly-patients (4) 4
epstein-barr virus (4) 4
expression (4) 4
genetic aspects (4) 4
genetic research (4) 4
infection (4) 4
leukemia, myeloid, acute - genetics (4) 4
lymphoma (4) 4
lymphoma, large b-cell, diffuse - drug therapy (4) 4
lymphoma, large b-cell, diffuse - virology (4) 4
medicine & public health (4) 4
pathology (4) 4
retrospective studies (4) 4
survival (4) 4
acute myeloid leukemia (3) 3
antibodies, monoclonal, murine-derived - therapeutic use (3) 3
chemotherapy plus rituximab (3) 3
chop (3) 3
diffuse large b‐cell lymphoma (3) 3
epstein-barr virus infections - complications (3) 3
epstein–barr virus (3) 3
gene (3) 3
herpesvirus 4, human (3) 3
lymphocytes b (3) 3
molecular docking (3) 3
non-hodgkins-lymphoma (3) 3
protein (3) 3
randomized controlled-trial (3) 3
recurrence (3) 3
rituximab - administration & dosage (3) 3
rna (3) 3
therapy (3) 3
toxicology (3) 3
young adult (3) 3
abridged index medicus (2) 2
acute myeloid-leukemia (2) 2
adolescent (2) 2
age (2) 2
anthraquinones (2) 2
antibodies, monoclonal, murine-derived - adverse effects (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
aplastic anemia (2) 2
apoptosis (2) 2
apoptosis - drug effects (2) 2
base sequence (2) 2
biochemistry & molecular biology (2) 2
care and treatment (2) 2
caspases (2) 2
caspases - metabolism (2) 2
cd8-positive t-lymphocytes - drug effects (2) 2
cell line, tumor (2) 2
classification (2) 2
cytochrome c (2) 2
cytochromes c - metabolism (2) 2
diseases (2) 2
dna (2) 2
dna, viral - blood (2) 2
eber (2) 2
ebv dna load (2) 2
epstein-barr virus infections - pathology (2) 2
follicular lymphoma (2) 2
further section (2) 2
genes (2) 2
geriatrics (2) 2
herpesvirus 4, human - isolation & purification (2) 2
in situ hybridization (2) 2
induction (2) 2
infectious diseases (2) 2
lymph nodes (2) 2
lymphoma, b-cell - drug therapy (2) 2
lymphoma, large b-cell, diffuse - mortality (2) 2
lymphoma, large b-cell, diffuse - pathology (2) 2
lymphoproliferative disorders - pathology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 05/2019, Volume 46, Issue 5, p. 878
Journal Article
International Journal of Hematology, ISSN 0925-5710, 8/2018, Volume 108, Issue 2, pp. 208 - 212
Journal Article
Cancer Science, ISSN 1347-9032, 11/2015, Volume 106, Issue 11, pp. 1576 - 1581
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4209 - 4209
Abstract Hepatitis B virus (HBV) surface antigen (HBsAg)-positive patients treated with anti-B-cell lymphoma therapy are at high risk of HBV reactivation;... 
Journal Article
Pathology International, ISSN 1320-5463, 01/2019, Volume 69, Issue 1, pp. 37 - 41
Elderly patients with Epstein‐Barr virus (EBV) infection are at increased risk for developing B‐cell lymphoproliferative disorder (B‐LPD) due to... 
EBV‐positive nodal polymorphous B‐LPD | EBV‐positive mucocutaneous ulcer | EBV‐associated B‐cell lymphoproliferative disorder | EBV‐positive diffuse large B‐cell lymphoma | EBV-associated B-cell lymphoproliferative disorder | EBV-positive nodal polymorphous B-LPD | EBV-positive mucocutaneous ulcer | EBV-positive diffuse large B-cell lymphoma | PATHOLOGY | Lymph Nodes - pathology | Humans | Male | Lymphoma, Large B-Cell, Diffuse - etiology | Ulcer - virology | Herpesvirus 4, Human - isolation & purification | Gingiva - pathology | Ulcer - pathology | B-Lymphocytes - virology | Immunosenescence | B-Lymphocytes - pathology | Mouth Mucosa - pathology | Lymphoproliferative Disorders - etiology | Gingiva - virology | Ulcer - etiology | Lymphoma, Large B-Cell, Diffuse - drug therapy | Epstein-Barr Virus Infections - virology | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoproliferative Disorders - virology | Lymph Nodes - metabolism | Lymphoproliferative Disorders - pathology | Remission Induction | Lymphoma, Large B-Cell, Diffuse - virology | Epstein-Barr Virus Infections - pathology | B7-H1 Antigen - metabolism | Mouth Mucosa - virology | Aged | Elderly people | Health risks | Viruses | Regression analysis | Lymphoma | Patients | Lymph nodes | Polymerase chain reaction | Chemotherapy | Lymphocytes B | Lymphocytes | Ulcers | Remission | Lymphomas | Lesions | Elderly | Geriatrics | Enlargement
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2010, Volume 116, Issue 20, pp. 4274 - 4283
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 8/2016, Volume 78, Issue 2, pp. 305 - 312
Journal Article
by Ishizaki, Jun and Takemori, Ayako and Suemori, Koichiro and Matsumoto, Takuya and Akita, Yoko and Sada, Ken-ei and Yuzawa, Yukio and Amano, Koichi and Takasaki, Yoshinari and Harigai, Masayoshi and Arimura, Yoshihiro and Makino, Hirofumi and Yasukawa, Masaki and Takemori, Nobuaki and Hasegawa, Hitoshi and Murakawa, Yohko and Muso, Eri and Komatsuda, Atsushi and Ito, Satoshi and Fujii, Takao and Kawakami, Atsushi and Nakaya, Izaya and Saito, Takao and Ito, Takafumi and Hirawa, Nobuhito and Yamamura, Masahiro and Nakano, Masaaki and Nitta, Kosaku and Ogura, Makoto and Naniwa, Taio and Ozaki, Shoichi and Hirahashi, Junichi and Ogawa, Noriyoshi and Hosoya, Tatsuo and Wada, Takashi and Horikoshi, Satoshi and Kawaguchi, Yasushi and Hayashi, Taichi and Yoshida, Masaharu and Watanabe, Tsuyoshi and Inaguma, Daijo and Tsuruya, Kazuhiko and Homma, Noriyuki and Takeuchi, Tsutomu and Nakagawa, Naoki and Takeda, Shinichi and Katabuchi, Ritsuko and Iwano, Masayuki and Atsumi, Tatsuya and Fujimoto, Shoichi and Banno, Shogo and Sugihara, Takahiko and Kobayashi, Masaki and Yamagata, Kunihiro and Homma, Sakae and Dobashi, Hiroaki and Tsuboi, Naotake and Ishizu, Akihiro and Sugiyama, Hitoshi and Minist Hlth Labour Welf Japan and Res Comm Intractable Vasculitis and Research Committee of Intractable Vasculitis Syndrome and the Research Committee of Intractable Renal Disease of the Ministry of Health, Labour and Welfare of Japan and for the Research Committee of Intractable Vasculitis Syndrome and the Research Committee of Intractable Renal Disease of the Ministry of Health, Labour and Welfare of Japan
Arthritis Research and Therapy, ISSN 1478-6354, 09/2017, Volume 19, Issue 1, pp. 218 - 17
Journal Article
Annals of Oncology, ISSN 0923-7534, 11/2015, Volume 26, Issue suppl 7, pp. vii96.5 - vii97
Journal Article